| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/25/2009 | CA2709126A1 Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy |
| 06/25/2009 | CA2709068A1 Benzofuran anilide histone deacetylase inhibitors |
| 06/25/2009 | CA2708822A1 Kinesin inhibitors as cancer therapeutics |
| 06/25/2009 | CA2708679A1 Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer |
| 06/25/2009 | CA2708113A1 Compounds for use in the treatment of cancer |
| 06/25/2009 | CA2708080A1 Antitumoral compounds |
| 06/25/2009 | CA2707773A1 Binding molecules to the human ox40 receptor |
| 06/25/2009 | CA2707637A1 Compositions and methods for treating osteolytic disorders comprising mmp-14 binding proteins |
| 06/24/2009 | EP2072619A1 Factor involved in metastasis and uses thereof |
| 06/24/2009 | EP2072525A1 New polypeptides having affinity for HER2 |
| 06/24/2009 | EP2072521A1 Octahedral metal (III) polypyridyl complexes and their use in prevention and treatment of cancer |
| 06/24/2009 | EP2072518A1 Stable Amorphous Form of Pemextred Disodium |
| 06/24/2009 | EP2072502A1 Sulfoximide substituted chinolin and chinazolin derivatives as kinase inhibitors |
| 06/24/2009 | EP2072082A2 N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3 sulfonamide as analgetic agent |
| 06/24/2009 | EP2072046A1 Use of a hydrocarbon-containing preparation for preventing or treating cardiac-circulatory diseases, diabetes, osteoporosis and chronic liver failure |
| 06/24/2009 | EP1954698B1 Spirocyclic compounds as hdac inhibitors |
| 06/24/2009 | EP1763526B1 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors |
| 06/24/2009 | EP1713769B1 Amorphous tamsulosin hydrochloride |
| 06/24/2009 | EP1590360A4 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases |
| 06/24/2009 | EP1499746A4 Method to inhibit cell growth using oligonucleotides |
| 06/24/2009 | EP1451333B1 Ul16 binding protein 4 |
| 06/24/2009 | EP1445258B1 Activator for peroxisome proliferator-activated receptor delta |
| 06/24/2009 | EP1385522B1 Combination comprising a signal transduction inhibitor and an epothilone derivative |
| 06/24/2009 | EP1339709B1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 06/24/2009 | EP1284977B1 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
| 06/24/2009 | EP1152761B1 Use of 5-ht3 receptor antagonists for treating musculoeskeletal diseases |
| 06/24/2009 | EP1131106B1 Compositions and methods for producing vascular occlusion |
| 06/24/2009 | EP1011733B1 Compositions and methods for enhancing delivery of therapeutic agents to cells |
| 06/24/2009 | CN100503829C Interleukin-18 mutants, their production and use |
| 06/24/2009 | CN100503639C Recombinant tumor specific antibody and use thereof |
| 06/24/2009 | CN100503635C Crystal of human avidin protein and preparation thereof |
| 06/24/2009 | CN100503611C New use of specific cyclolignans |
| 06/24/2009 | CN100503608C Deazapurines and uses thereof |
| 06/24/2009 | CN100503607C Yageine derivative compounds and their uses |
| 06/24/2009 | CN100503602C Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
| 06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/24/2009 | CN100503598C Improved chemical process and pharmaceutical formulation |
| 06/24/2009 | CN100503580C Irreversible inhibitor of tyrosine kinase |
| 06/24/2009 | CN100503572C Caspase inhibitors and uses thereof |
| 06/24/2009 | CN100503570C Cyanoguanidine prodrugs |
| 06/24/2009 | CN100503567C Method for preparing-4-bromine-7-methyl isatin |
| 06/24/2009 | CN100503560C Substituted cyclohexane derivatives |
| 06/24/2009 | CN100503435C Nano level active carbon and its preparation and use |
| 06/24/2009 | CN100502876C Thiophenepyrimidinones as 17-beta-hydroxysteroid dehydrogenase inhibitors |
| 06/24/2009 | CN100502863C 2,4,5-trisubstituded thiazolyl derivatives and their anti-inflammatory activity |
| 06/24/2009 | CN100502846C 3,4,5,-substituted benzyl ethylene derivatives and their preparation and use |
| 06/23/2009 | USRE40792 treating CANCER, PMS, MENOPAUSE AND HYPERCHOLESTEROLEMIA with plant extract of soya or clover and isoflavones from Genistein, Daidzein, Biochanin A, Formononetin or the natural glycosides; dosage forms |
| 06/23/2009 | US7550609 Biological conjugates for tumor targeted treatment; novel taxanes having mercapto or disulfide groups; side effect reduction without compromising their cytotoxicity |
| 06/23/2009 | US7550597 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 06/23/2009 | US7550587 Photosensitizer and method for production thereof |
| 06/23/2009 | US7550582 labeled Peptide Nucleic Acid (PNA) derivatives which carry one or more phosphoryl radicals at the N terminus of the PNA backbone for fluorescence in-situ hybridization (FISH) detection; can be purified using chromatography or electrophoresis; use as pharmaceuticals and diagnostic agents |
| 06/23/2009 | US7550580 heat shock protein 27 inhibitors; RNA interference; nuclease resistance |
| 06/23/2009 | US7550503 Macrolide compounds comprising 18,19-epoxytricosa-8,12,14-trien-11-olide derivatives; angiogenesis inhibitors; anticarcinogenic, antimetastasis, antiinflammatory, and antitumor agents; antihypoxic agents; endothelial growth factor suppressors; retinal neovascularization, diabetic retinopathy |
| 06/23/2009 | US7550496 Hypoxia-activated prodrugs of alkylating agents such as of cyclophosphamide, ifosfamide, melphalan, chlorambucil, thiotepa; protected with 2-nitroimidazolyl group; targeted cancer cells more effectively, side effect reduction |
| 06/23/2009 | US7550490 Cancer and psoriasis; e.g. N-(2-amino-4-fluorophenyl)-4-[N-(Pyridin-3-ylacryloyl)aminomethyl]benzamide |
| 06/23/2009 | US7550470 Substituted pyrazolo[1,5-A]pyrimidines as tyrosine kinase inhibitors |
| 06/23/2009 | US7550453 Anticancer agents; colon cancer or hepatocellular carcinoma; analogs of bengamide where the caprolactam ring is changed and/or substituted e.g. N-(2-Methyl-3-oxo-2,3,4,5-tetrahydro-1H-2-benzazepin-4-yl)-(E)-(2R,3R,4S,5R)-3,4,5-trihydroxy-2-methoxy-8,8-dimethylnon-6-enamide |
| 06/23/2009 | US7550449 4-(alkylcarbonyloxymethyl)-2-oxo-2-methoxy-1,2-oxaphospholane; anticancer, antimetastasis agents |
| 06/23/2009 | US7550429 treating mammal to a weight reduction or reduction in obesity; biodrug as antilipolytic agents |
| 06/23/2009 | US7550159 For treatment of cancer and autoimmune diseases; kits |
| 06/23/2009 | US7550147 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 06/23/2009 | US7550145 Adjuvant compositions |
| 06/23/2009 | US7550142 Anti-integrin antibodies, compositions, methods and uses |
| 06/23/2009 | US7550140 Stimulation of human T-cells and used to enhance antigen-specific immune responses; immunotherapy |
| 06/23/2009 | CA2492804C Novel inhibitors of kinases |
| 06/23/2009 | CA2402991C Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases |
| 06/23/2009 | CA2389219C Dry powder compositions having improved dispersivity |
| 06/23/2009 | CA2337494C Herpes virus vectors for dendritic cells |
| 06/23/2009 | CA2326833C Indolyl-3-glyoxylic acid derivatives with antitumoral activity |
| 06/23/2009 | CA2214131C Trisubstituted phenyl derivatives |
| 06/18/2009 | WO2009076629A2 Compositions and methods for treating cancer |
| 06/18/2009 | WO2009076598A1 Use of unsaturated sphingosine compounds as chemotherapeutic agents for the treatment of cancer |
| 06/18/2009 | WO2009076473A1 2-{[2-(substituted amino)ethyl]sulfonyl}ethyl n,n-bis(2- chloroethyl)phosphorodiamidates |
| 06/18/2009 | WO2009076455A2 Methods of treating hematologic cancers using pnp inhibitors such as forodesine in combination with alkylating agents or anti-cd20 agents |
| 06/18/2009 | WO2009076434A1 Inhibitors of integrin vla-4 |
| 06/18/2009 | WO2009076397A2 Antiviral activity of cyclopentene nitro-ester and derivatives |
| 06/18/2009 | WO2009076388A2 Targeting vector-phospholipid conjugates |
| 06/18/2009 | WO2009076234A2 Synthesis methods of histone deacetylase inhibitors (hdacis) |
| 06/18/2009 | WO2009076212A1 Catalytic topoisomerase ii inhibitors |
| 06/18/2009 | WO2009076170A2 Combinations of therapeutic agents for treating cancer |
| 06/18/2009 | WO2009075870A1 Compounds and methods for the treatment of cancer |
| 06/18/2009 | WO2009075841A2 Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of antecedent hematologic disorders |
| 06/18/2009 | WO2009075826A1 Methods for increasing white blood cells |
| 06/18/2009 | WO2009075610A1 Use of benomyl fungicide as an agent for treating oncological diseases |
| 06/18/2009 | WO2009075583A1 Use of particles comprising an alcohol |
| 06/18/2009 | WO2009075556A1 Method for sensitising cells and the use of same for treating tumours |
| 06/18/2009 | WO2009075349A1 Element retained in blood showing degradability selectively in tumor tissue |
| 06/18/2009 | WO2009075344A1 Therapeutic agent for mll leukemia and moz leukemia of which molecular target is m-csf receptor, and use thereof |
| 06/18/2009 | WO2009075334A1 Uterine fibroid cell growth inhibitor, and prophylactic or therapeutic agent for uterine fibroid comprising the inhibitor |
| 06/18/2009 | WO2009075277A1 4-aminopyrimidine derivative and medicinal composition containing the compound |
| 06/18/2009 | WO2009074862A1 Polymorphic forms of a 3-pyrrole substituted 2-indolinone |
| 06/18/2009 | WO2009074827A2 Combination comprising a mek inhibitor and an aurora kinase inhibitor |
| 06/18/2009 | WO2009074811A2 Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis |
| 06/18/2009 | WO2009074809A1 Sigma ligands and ikk / nf - kb inhibitors for medical treatment |
| 06/18/2009 | WO2009074749A2 Nicotinamide derivatives, preparation thereof and therapeutic use thereof |
| 06/18/2009 | WO2009074743A1 Pyrazolo-pyrazines derivatives used as g protein inhibitors |
| 06/18/2009 | WO2009074707A1 Grk2 antitumour therapy |
| 06/18/2009 | WO2009074678A2 Anticancer conjugates of camptothecin to hyaluronic acid |
| 06/18/2009 | WO2009074305A1 Gold xanthogenates and medicaments comprising them |
| 06/18/2009 | WO2009074300A2 Hedgehog pathway antagonists and therapeutic applications thereof |